Skip to content

Analysis of clinical features of AIDS with cryptococcal meningitis and the characteristics of Th1/Th2 Cytokine in cerebrospinal fluid

Analysis of clinical features of AIDS with cryptococcal meningitis and the characteristics of Th1/Th2 Cytokine in cerebrospinal fluid

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024565
Enrollment
Unknown
Registered
2019-07-16
Start date
2019-07-31
Completion date
Unknown
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS complicated with cryptococcal meningitis

Interventions

Case group:none
Control group:Nil

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: AIDS combined with CM patients into the group criteria: 1. AIDS patients in our hospital infection center combined with CM patients, gender and age are not limited; 2. AIDS and CM diagnostic criteria in line with the 2015 Ministry of Health of the People's Republic of China "AIDS treatment guidelines (The third edition) and the 2018 edition of the United States "Guidelines for the Prevention and Treatment of Opportunistic Infections for Adults and Adolescents with HIV Infection". All patients were positive for anti-HIV-1 antibodies by enzyme-linked immunosorbent assay (ELISA) screening and Western blotting (WB). The diagnostic criteria for CM: cerebrospinal fluid smear staining can be seen as positive for Cryptococcus neoformans or culture; 3. patients in the prospective cohort require initial HIV antibody positive and HAART has not been initiated; 4. can be combined with treatment and monitoring, signed informed consent Booker. HIV negative control population (n=20), age matched with AIDS and CM patients. HIV-negative controls were selected from hospitalized patients with neurosyphilis in our hospital infection center. The inclusion criteria required no central nervous system infection and could be checked and voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: Case group: (1) Patients who are unable to cooperate with treatment and monitoring and incomplete clinical data; (2) Those who refuse to sign informed consent. Control group: Those who were suspected or had a central nervous system infection, could not cooperate with the examination, and refused to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Cytokine;

Countries

China

Contacts

Public ContactLi Aixin

Beijing You'an Hospital, Capital Medical University

liaixin8194@sina.com+86 13264161606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026